Brokerages Set Silicon Laboratories Inc. (NASDAQ:SLAB) PT at $136.20

Silicon Laboratories Inc. (NASDAQ:SLAB) has earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $136.20.

Several analysts recently commented on SLAB shares. Susquehanna initiated coverage on shares of Silicon Laboratories in a report on Tuesday, December 17th. They set a “neutral” rating and a $130.00 target price for the company. StockNews.com cut Silicon Laboratories from a “hold” rating to a “sell” rating in a report on Friday. Barclays increased their target price on Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Friday, January 17th. Stifel Nicolaus boosted their price target on Silicon Laboratories from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Monday, January 6th. Finally, Needham & Company LLC increased their price objective on Silicon Laboratories from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Wednesday, February 5th.

Insider Buying and Selling at Silicon Laboratories

In other Silicon Laboratories news, Director Navdeep S. Sooch sold 2,360 shares of the firm’s stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total value of $351,640.00. Following the sale, the director now owns 400,567 shares of the company’s stock, valued at approximately $59,684,483. This trade represents a 0.59 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director William G. Bock sold 2,000 shares of Silicon Laboratories stock in a transaction on Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total value of $281,540.00. Following the completion of the transaction, the director now owns 32,115 shares in the company, valued at approximately $4,520,828.55. The trade was a 5.86 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.72% of the company’s stock.

Institutional Investors Weigh In On Silicon Laboratories

A number of hedge funds have recently made changes to their positions in the stock. FMR LLC lifted its stake in Silicon Laboratories by 0.5% in the 4th quarter. FMR LLC now owns 4,867,203 shares of the semiconductor company’s stock valued at $604,604,000 after purchasing an additional 23,833 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Silicon Laboratories by 1.9% during the fourth quarter. Vanguard Group Inc. now owns 3,959,580 shares of the semiconductor company’s stock worth $491,859,000 after buying an additional 71,942 shares in the last quarter. Capital Research Global Investors lifted its stake in shares of Silicon Laboratories by 23.3% in the 4th quarter. Capital Research Global Investors now owns 2,131,920 shares of the semiconductor company’s stock valued at $264,827,000 after acquiring an additional 403,010 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of Silicon Laboratories by 28.3% during the 3rd quarter. Wellington Management Group LLP now owns 888,382 shares of the semiconductor company’s stock valued at $102,670,000 after acquiring an additional 195,997 shares in the last quarter. Finally, Geode Capital Management LLC grew its position in Silicon Laboratories by 2.1% during the 3rd quarter. Geode Capital Management LLC now owns 781,049 shares of the semiconductor company’s stock worth $90,282,000 after acquiring an additional 15,728 shares during the last quarter.

Silicon Laboratories Stock Performance

Silicon Laboratories stock opened at $149.54 on Monday. The stock has a 50-day simple moving average of $133.35 and a 200 day simple moving average of $118.22. The stock has a market capitalization of $4.85 billion, a P/E ratio of -25.18 and a beta of 1.16. Silicon Laboratories has a 52 week low of $94.00 and a 52 week high of $154.91.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.11). Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The business had revenue of $166.25 million for the quarter, compared to analysts’ expectations of $166.09 million. During the same quarter in the prior year, the business earned ($1.19) EPS. The firm’s revenue for the quarter was up 91.4% on a year-over-year basis. Research analysts forecast that Silicon Laboratories will post -0.47 earnings per share for the current year.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.